{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:24:34Z","timestamp":1793823874365,"version":"4.6.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-025-04043-6","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T10:26:46Z","timestamp":1744626406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["CDK4\/6 inhibitor-associated vortex keratopathy: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Lian","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghuai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"4","key":"4043_CR1","doi-asserted-by":"publisher","first-page":"e23901","DOI":"10.7759\/cureus.23901","volume":"14","author":"S Reddy","year":"2022","unstructured":"Reddy S, Barkhane Z, Elmadi J, Satish Kumar L, Pugalenthi LS, Ahmad M. Cyclin-Dependent kinase 4 and 6 inhibitors: A quantum leap in the treatment of advanced breast cancers. Cureus. 2022;14(4):e23901. https:\/\/doi.org\/10.7759\/cureus.23901.","journal-title":"Cureus"},{"issue":"9","key":"4043_CR2","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1634\/theoncologist.2017-0142","volume":"22","author":"LM Spring","year":"2017","unstructured":"Spring LM, Zangardi ML, Moy B, Bardia A. Clinical management of potential toxicities and drug interactions related to Cyclin-Dependent kinase 4\/6 inhibitors in breast cancer: practical considerations and recommendations. Oncologist. 2017;22(9):1039\u201348. https:\/\/doi.org\/10.1634\/theoncologist.2017-0142.","journal-title":"Oncologist"},{"issue":"3","key":"4043_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.survophthal.2016.11.008","volume":"62","author":"MB Raizman","year":"2017","unstructured":"Raizman MB, Hamrah P, Holland EJ, Kim T, Mah FS, Rapuano CJ, et al. Drug-Induced corneal epithelial changes. Surv Ophthalmol. 2017;62(3):286\u2013301. https:\/\/doi.org\/10.1016\/j.survophthal.2016.11.008.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"4043_CR4","doi-asserted-by":"publisher","first-page":"2226909","DOI":"10.1080\/07853890.2023.2226909","volume":"55","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhang W, Yao X, Song W, Zhao Y, Yuan Y, et al. Investigation of ocular involvement in patients with Fabry disease. Ann Med. 2023;55(1):2226909. https:\/\/doi.org\/10.1080\/07853890.2023.2226909.","journal-title":"Ann Med"},{"issue":"3","key":"4043_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbalip.2012.08.013","volume":"1831","author":"JA Shayman","year":"2013","unstructured":"Shayman JA, Abe A. Drug induced phospholipidosis: an acquired lysosomal storage disorder. Biochim Biophys Acta. 2013;1831(3):602\u201311. https:\/\/doi.org\/10.1016\/j.bbalip.2012.08.013.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"4043_CR6","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/opx.0000000000001534","volume":"97","author":"M Alshehri","year":"2020","unstructured":"Alshehri M, Joury A. Ocular adverse effects of Amiodarone: A systematic review of case reports. Optometry Vis Science: Official Publication Am Acad Optometry. 2020;97(7):536\u201342. https:\/\/doi.org\/10.1097\/opx.0000000000001534.","journal-title":"Optometry Vis Science: Official Publication Am Acad Optometry"},{"key":"4043_CR7","doi-asserted-by":"publisher","unstructured":"Zhang J, Liu R, Gao S, Chen W, Han X, Ma Y et al. Bpi-16350, a novel promising Cdk4\/6 inhibitor for Hr+\/Her2- metastatic breast cancer (Mbc): results from a phase I study. (2023) 41(16_suppl):e13051\u2013e.https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.e13051","DOI":"10.1200\/JCO.2023.41.16_suppl.e13051"},{"key":"4043_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2147\/cia.S66690","volume":"9","author":"S Martinkovich","year":"2014","unstructured":"Martinkovich S, Shah D, Planey SL, Arnott JA. Selective Estrogen receptor modulators: tissue specificity and clinical utility. Clin Interv Aging. 2014;9:1437\u201352. https:\/\/doi.org\/10.2147\/cia.S66690.","journal-title":"Clin Interv Aging"},{"issue":"4","key":"4043_CR9","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1016\/j.jcjo.2019.11.003","volume":"55","author":"D Saeed","year":"2020","unstructured":"Saeed D, Hussain A. Ribociclib-Associated vortex keratopathy. Can J Ophthalmol J Canadien D\u2019ophtalmologie. 2020;55(4):e140\u20132. https:\/\/doi.org\/10.1016\/j.jcjo.2019.11.003.","journal-title":"Can J Ophthalmol J Canadien D\u2019ophtalmologie"},{"issue":"1","key":"4043_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/10781552221101799","volume":"29","author":"A T\u00fcrkel","year":"2023","unstructured":"T\u00fcrkel A, \u00d6zdo\u011fan S, Yeked\u00fcz E, \u015eeyran E, Kara\u00e7in C, Ate\u015f \u00d6. Vortex keratopathy associated with ribociclib. J Oncol Pharm Practice: Official Publication Int Soc Oncol Pharm Practitioners. 2023;29(1):230\u20132. https:\/\/doi.org\/10.1177\/10781552221101799.","journal-title":"J Oncol Pharm Practice: Official Publication Int Soc Oncol Pharm Practitioners"},{"key":"4043_CR11","doi-asserted-by":"publisher","unstructured":"Bilen NB, Tar\u0131m B, Hamurcu M, Ulusoy DM. Bilateral epithelial keratopathy and punctate keratitis due to ribociclib. J Oncol Pharm Practice: Official Publication Int Soc Oncol Pharm Practitioners. 2024;10781552241301406. https:\/\/doi.org\/10.1177\/10781552241301406.","DOI":"10.1177\/10781552241301406"},{"issue":"4","key":"4043_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00417-008-0962-9","volume":"247","author":"K Falke","year":"2009","unstructured":"Falke K, B\u00fcttner A, Schittkowski M, Stachs O, Kraak R, Zhivov A, et al. The microstructure of cornea verticillata in Fabry disease and Amiodarone-Induced keratopathy: A confocal Laser-Scanning microscopy study. Graefe\u2019s Archive Clin Experimental Ophthalmol = Albrecht Von Graefes Archiv fur Klinische Und Experimentelle Ophthalmologie. 2009;247(4):523\u201334. https:\/\/doi.org\/10.1007\/s00417-008-0962-9.","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol = Albrecht Von Graefes Archiv fur Klinische Und Experimentelle Ophthalmologie"},{"issue":"11","key":"4043_CR13","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00417-011-1726-5","volume":"249","author":"J Wasielica-Poslednik","year":"2011","unstructured":"Wasielica-Poslednik J, Pfeiffer N, Reinke J, Pitz S. Confocal Laser-Scanning microscopy allows differentiation between Fabry disease and Amiodarone-Induced keratopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249(11):1689\u201396. https:\/\/doi.org\/10.1007\/s00417-011-1726-5.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"20","key":"4043_CR14","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1038\/s41388-019-0695-8","volume":"38","author":"S Llanos","year":"2019","unstructured":"Llanos S, Megias D, Blanco-Aparicio C, Hern\u00e1ndez-Encinas E, Rovira M, Pietrocola F, et al. Lysosomal trapping of Palbociclib and its functional implications. Oncogene. 2019;38(20):3886\u2013902. https:\/\/doi.org\/10.1038\/s41388-019-0695-8.","journal-title":"Oncogene"},{"key":"4043_CR15","doi-asserted-by":"publisher","unstructured":"Swamynathan S, Campbell G, Tiwari A, Swamynathan SK. Secreted Ly-6\/Upar-Related Protein-1 (Slurp1) Is a Pro-Differentiation Factor That Stalls G1-S Transition During Corneal Epithelial Cell Cycle Progression. The ocular surface (2022) 24:1\u201311.https:\/\/doi.org\/10.1016\/j.jtos.2021.12.006","DOI":"10.1016\/j.jtos.2021.12.006"},{"issue":"1","key":"4043_CR16","doi-asserted-by":"publisher","first-page":"e000943","DOI":"10.1136\/bmjophth-2021-000943","volume":"7","author":"JY Sahyoun","year":"2022","unstructured":"Sahyoun JY, Sabeti S, Robert MC. Drug-Induced corneal deposits: an up-to-Date review. BMJ Open Ophthalmol. 2022;7(1):e000943. https:\/\/doi.org\/10.1136\/bmjophth-2021-000943.","journal-title":"BMJ Open Ophthalmol"},{"key":"4043_CR17","doi-asserted-by":"publisher","unstructured":"Vitiello L, Lixi F, Coco G, Giannaccare G. Ocular surface side effects of novel anticancer drugs. Cancers. 2024;16(2). https:\/\/doi.org\/10.3390\/cancers16020344.","DOI":"10.3390\/cancers16020344"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-04043-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-04043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T10:26:46Z","timestamp":1744626406000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-04043-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4043"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-04043-6","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained for publication from the patient in our case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}